16 results match your criteria: "Groupe Hospitalier Sainte-Anne[Affiliation]"
Purpose: The aim of this study was to compare the diagnostic performance of the rabbit visual pattern versus the one endorsed by the EANM/SNMMI for the diagnosis of parkinsonian syndromes in PET/MRI.
Patients And Methods: The 18F-DOPA PET images of 129 consecutive patients (65 Park+ and 64 controls) with 1 year of clinical follow-up were reviewed independently by 5 experienced readers on the same imaging workstation, blinded to the final clinical diagnosis. Two visual methods were assessed independently, with several days to months of interval: the criteria endorsed by EANM/SNMMI and the "rabbit" shape of the striate assessed on 3D MIP images.
Heart
September 2021
Hôpital Bellier, Pole Hospitalo-Universitaire de Gérontologie Clinique, CHU de Nantes, F-44000 Nantes, France.
Soins Psychiatr
August 2018
CMME Groupe hospitalier Sainte-Anne, 100, rue de la Santé, 75014 Paris, France; Université Paris-Descartes, 12, rue de l'École de Médecine, 75006 Paris, France; Inserm UMR894, Centre de psychiatrie et neurosciences, 2 ter, rue d'Alésia, 75014 Paris, France. Electronic address:
J Affect Disord
February 2018
CMME (Groupe Hospitalier Sainte-Anne), Paris Descartes University, France.
Background: Seasonal affective disorder (SAD) is mainly characterized by a seasonal pattern of depressive recurrences over the years. However, few studies have been conducted on the long-term course of patients with SAD, whose findings raised questions about the diagnosis stability over time. This study aimed to better characterize the diagnosis evolution, and determine prognosis markers.
View Article and Find Full Text PDFDepress Anxiety
February 2017
CMME (Groupe Hospitalier Sainte-Anne), Université Paris Descartes, Paris, France.
Background: Functional recovery after a major depressive episode (MDE) requires both clinical remission and preservation of cognitive skills. As attentional deficit may persist after remission, leading to functional impairment, its role as a prognosis marker needs to be considered.
Methods: Five hundred eight depressed outpatients (DSM-IV) were assessed at baseline for clinical symptoms (QIDS-SR), social functioning (Sheehan Disability Scale, SDS) and attention through the d2 test of attention and the trail making test, simple tests, respectively, requiring to quote or to interconnect relevant items.
J Affect Disord
November 2016
AP-HP, Corentin Celton Hospital, Department of Psychiatry, 92130 Issy-les-Moulineaux, France; Paris Descartes University, PRES Sorbonne Paris Cité, Paris, France; INSERM UMR 894, Psychiatry and Neurosciences Center, Paris, France.
Background: The inclusion of subsyndromal forms of bipolarity in the fifth edition of the DSM has major implications for the way in which we approach the diagnosis of individuals with depressive symptoms. The aim of the present study was to use methods based on item response theory (IRT) to examine whether, when equating for levels of depression severity, there are differences in the likelihood of reporting DSM-IV symptoms of major depressive episode (MDE) between subjects with and without a lifetime history of manic symptoms.
Methods: We conducted these analyses using a large, nationally representative sample from the USA (n=34,653), the second wave of the National Epidemiologic Survey on Alcohol and Related Conditions.
Psychol Med
December 2015
Department of Psychiatry & Douglas Mental Health University Institute,McGill Group for Suicide Studies, McGill University,Montréal (Québec),Canada.
Background: Impaired decision-making is a potential neurocognitive phenotype of eating disorders. It is therefore important to disentangle the decision-making deficits associated with the eating disorder subtypes and determine whether this putative impairment is a state or trait marker of the disease or more related to starvation. We systematically reviewed the literature on decision-making in eating disorders and conducted a meta-analysis to explore its role in anorexia nervosa (AN), bulimia nervosa (BN) and binge-eating disorder (BED).
View Article and Find Full Text PDFEncephale
April 2015
Inserm U894, centre de psychiatrie et neurosciences (CPN), Paris, France; Université Paris-Descartes, Paris-Sorbonne-Cité, 75005 Paris, France; Clinique des maladies mentales et de l'encéphale (CMME), groupe hospitalier Sainte-Anne, 100, rue de la Santé, 75014 Paris, France. Electronic address:
Background: There are numerous risk factors involved in poor (incomplete) compliance to pharmacological treatment, and the associated relapse risk, for patients with schizophrenia. Comorbid substance use disorders are considered as among the most important ones, although how much their presence increase the risk of poorer observance (and higher risk of relapse) has not been yet assessed. This measure would be important, especially if the published literature on the topic provides sufficient material to perform a meta-analysis and to assess different potential biases such as those related to time (new studies are easier to publish when positive) or sample size (small samples might drive the global positive conclusion).
View Article and Find Full Text PDFPsychiatry Res
May 2015
Laboratoire de Psychologie des Pays de la Loire, UPRES EA 4638, Université d׳Angers, Angers, France; McGill University, Department of Psychiatry & Douglas Mental Health University Institute McGill Group for Suicide Studies, Montréal (Québec), Canada. Electronic address:
Three components of cognitive inhibition were compared in patients with schizophrenia and healthy controls. Nineteen patients with schizophrenia were compared to 30 healthy controls, matched for age, sex, and educational level. Cognitive inhibition was examined by (i) access to relevant information (Reading with distraction task), (ii) suppression of no longer relevant information (Trail Making Test B), and (iii) restraint of cognitive resources to relevant information (Stroop Test, Hayling Sentence Completion Test, Go/No-Go Test).
View Article and Find Full Text PDFInt Psychogeriatr
September 2015
CMME (Groupe Hospitalier Sainte-Anne), Université Paris Descartes,Paris,France.
Background: Older patients may be more vulnerable to the deleterious effect of depressive episodes on delayed narrative memory, a cognitive task which reflects hippocampal activity. We aimed to disentangle which factors could explain such increased vulnerability in the elderly, including the poorer response to treatment, a longer lifetime exposure to past depressive episodes, and lower baseline memory skills.
Methods: From an initial sample of 8,229 depressed outpatients, we focused on the 2,424 treatment responders, and compared older (65 years old and over, N = 233) to younger (N = 2,191) ones.
Neuropsychiatr Dis Treat
October 2014
Clinic Hospital, Spanish Mental Health Network (CIBERSAM), University of Valencia, Valencia, Spain.
Introduction: Prompt administration of antipsychotic treatment that is adhered to is essential for the optimal treatment of schizophrenia. Many patients have benefited from the advent of second-generation antipsychotics, which can offer good symptomatic control with reduced incidence of extrapyramidal symptoms, although with higher risk of metabolic side effects. It is unsurprising that accounts as to whether first- and second-generation antipsychotics differ in their efficacy vary, since treatment effectiveness is a broad notion and difficult to define.
View Article and Find Full Text PDFEur Neuropsychopharmacol
October 2014
CMME (Groupe Hospitalier Sainte-Anne), Université Paris Descartes, Paris, France.
The cumulative duration of depressive episodes, and their repetition, has a detrimental effect on depression recurrence rates and the chances of antidepressant response, and even increases the risk of dementia, raising the possibility that depressive episodes could be neurotoxic. Psychomotor retardation could constitute a marker of this negative burden of past depressive episodes, with conflicting findings according to the use of clinical versus cognitive assessments. We assessed the role of the Retardation Depressive Scale (filled in by the clinician) and the time required to perform the neurocognitive d2 attention test and the Trail Making Test (performed by patients) in a sample of 2048 depressed outpatients, before and after 6 to 8 weeks of treatment with agomelatine.
View Article and Find Full Text PDFEncephale
April 2014
Service de psychiatrie de l'adulte et du sujet âgé, hôpital Corentin-Celton, groupe hospitalier des hôpitaux universitaires Paris-Ouest, Assistance publique-Hôpitaux de Paris (AP-HP), 4, parvis Corentin-Celton, 92130 Issy-les-Moulineaux, France; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France; Inserm, centre de psychiatrie et neurosciences, UMR 894, 75014 Paris, France.
Background: Data on the frequency of high-risk alcohol consumption and its medical and social consequences in the French general population remain fragmented. Therefore, our aim was two-fold: (i) to assess the prevalence of different patterns of alcohol consumption using the AUDIT-C scale, according to two different perspectives, i.e.
View Article and Find Full Text PDFEncephale
April 2014
Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France; Inserm, centre de psychiatrie et neurosciences, UMR 894, 75014 Paris, France; Clinique des maladies mentales et de l'encéphale (CMME), groupe hospitalier Sainte-Anne, 75014 Paris, France.
Background: Data on the natural caregivers burdened by the excessive consumption of alcohol by members of the family circle or friends in the general population are lacking. Therefore, our aim was twofold: (i) to assess the burden of individuals with excessive alcohol consumption on natural caregivers and (ii) to examine the factors explaining the association between alcohol consumption and the level of burden.
Method: Data were derived from a national representative survey of the French adult population, conducted in 2013, that involved 1018 participants who had in their close environment a person consuming excessive amounts of alcohol.
Hum Genet
June 2012
Groupe Hospitalier Sainte-Anne, CMME, 100 rue de la Santé, Paris, France.
Dopamine plays a key role in reward behavior, yet the association of drug dependence as a chronic, relapsing disorder with the genes encoding the various dopaminergic receptor subtypes remains difficult to delineate. In the context of subsequent genome-wide association (GWAS) research and post-GWAS investigations, we summarize the novel data that link genes encoding molecules involved in the dopaminergic system (dopamine receptors, transporter and enzymes in charge of its metabolism) to drug addiction. Recent reports indicate that the heritability of drug addiction should be high enough to allow a significant role for a specific set of genes, and the available genetic studies, which might not be already conclusive because of the heterogeneity of designs, methods and recruited samples, should support the idea of a significant role of at least one gene related to dopaminergic system.
View Article and Find Full Text PDF